With 1 mL bacteriostatic water
10.0 units
Page last checked
Reconstitution · PEG-MGF
Pick the vial, the water you added and the dose. Get the exact draw in units for the syringe in your hand.
Step 1 of 4
This vial holds 2,000 mcg in total.
U-100 insulin syringe · 1 mL · lines every 2 units · 1 unit = 0.01 mL
20.0 units on a U-100 insulin syringe · 1 mL · lines every 2 units, which is 0.20 milliliters. The draw lands on a syringe line.
Your address is used to send this one card. The email also includes an optional link for updates when our data changes. Nothing else is sent unless you choose that link, and you can unsubscribe anytime.
PEG-MGF is a short piece of a growth factor your muscle makes for itself after hard exercise. A polyethylene glycol chain is attached to it, to slow down how fast it clears. It is sold for muscle repair and growth after training.
Nobody has given it to a person in a study. The human research here biopsies muscle and measures what the body makes on its own. Even that research disagrees about whether training raises it at all. The only work on the peptide went onto cultured cells and mice, using a fragment with no glycol chain on it.
No completed controlled human trial has shown which dose works for PEG-MGF. The range people report using is not a study result, tested schedule or recommendation.
no human dose shown to work
Each row uses 2 mg and the liquid volume shown. Dividing the amount by that volume gives the calculated concentration. The rows are arithmetic examples, not alternative product preparations.
With 1 mL bacteriostatic water
10.0 units
With 2 mL bacteriostatic water
20.0 units
With 3 mL bacteriostatic water
30.0 units
| Bacteriostatic water | Concentration | Per U-100 unit | Draw for 200 mcg | Nearest syringe line |
|---|---|---|---|---|
| 1 mL | 2.00 mg/mL | 20.0 mcg | 10.0 u · 0.100 mL | exactly 10 u |
| 2 mL | 1.00 mg/mL | 10.0 mcg | 20.0 u · 0.200 mL | exactly 20 u |
| 3 mL | 0.67 mg/mL | 6.7 mcg | 30.0 u · 0.300 mL | exactly 30 u |
The amount, liquid volume and dose shown here are the calculator’s starting example for PEG-MGF. Replace them with your own values. Every result in the table is calculated from those inputs.
Adding more water does not create more PEG-MGF. With the same vial amount and dose entered, it makes each calculated draw larger while leaving the dose count unchanged. The presets show this arithmetic; they do not establish a mixing instruction or dosing schedule.
Choose from one vial-size preset and three water presets. At the default dose, all three calculated draws fit within a U-100 barrel and land on a whole unit mark. Those results apply to the default inputs, not every amount you could enter.
A larger water volume lowers the concentration. The tool therefore returns more liquid for the same dose mass. Keeping the old syringe reading after changing the concentration would represent a different amount.
PEG-MGF has a polyethylene glycol chain attached to the peptide. It is distinct from an unmodified MGF fragment. Sharing part of a name does not make the two substances interchangeable.
The calculator cannot analyze a vial or resolve an unclear description of its strength. Its result uses the mass supplied as an input. A neat syringe reading does not confirm that input, the identity of the contents or their purity.
The calculated number of full doses comes from vial mass divided by dose mass, rounded down. Frequency is a separate input needed to turn that count into days of supply. Changing water alone changes neither of those mass values.
The cited review describes inconsistent reported schedules. A supply estimate cannot resolve them, establish an effective regimen or show how long the mixed product remains usable. Those limits still apply when the volume calculation is exact.
The cited review describes PEG-MGF use at different frequencies and explicitly warns that the collected protocols are inconsistent. The amount is reported practice, not a tested human regimen. These reports do not resolve which schedule, if any, is effective.
A quantity repeated daily consumes a vial differently from the same quantity used a few times a week. A days-of-supply figure is only as meaningful as the frequency entered. It cannot settle the review’s conflicting reports.
Adding a polyethylene glycol chain changes the molecule. Work on an unmodified MGF fragment does not directly establish how PEG-MGF behaves in people. The shared part of the name is not enough to transfer a result.
The review describes use under the skin and into muscle. The tool does not choose between those routes. A liquid-volume result cannot establish which route, if any, is appropriate.
A quantity repeated daily consumes a vial differently from the same quantity used a few times a week. A days-of-supply figure is only as meaningful as the frequency entered. It cannot settle the review’s conflicting reports.
Adding a polyethylene glycol chain changes the molecule. Work on an unmodified MGF fragment does not directly establish how PEG-MGF behaves in people. The shared part of the name is not enough to transfer a result.
The review describes use under the skin and into muscle. The tool does not choose between those routes. A liquid-volume result cannot establish which route, if any, is appropriate.
Mix 2 mg into 2 mL and one U-100 unit carries 10.0 mcg. The table shows how much peptide is in each numbered syringe line. These are conversion examples, not suggested doses.
| U-100 line | Volume | Mass (mcg) | Mass (mg) |
|---|---|---|---|
| 10 u | 0.10 mL | 100 mcg | 0.1 mg |
| 20 u | 0.20 mL | 200 mcg | 0.2 mg |
| 30 u | 0.30 mL | 300 mcg | 0.3 mg |
| 40 u | 0.40 mL | 400 mcg | 0.4 mg |
| 50 u | 0.50 mL | 500 mcg | 0.5 mg |
| 60 u | 0.60 mL | 600 mcg | 0.6 mg |
| 70 u | 0.70 mL | 700 mcg | 0.7 mg |
| 80 u | 0.80 mL | 800 mcg | 0.8 mg |
| 90 u | 0.90 mL | 900 mcg | 0.9 mg |
| 100 u | 1.00 mL | 1,000 mcg | 1 mg |
The math is only one part of the question. These guides cover the compound, published doses, side effects, mixing steps and supplies.